NCT01586572View on ClinicalTrials.gov

Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3

NACompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Polio
Interventions
DRUG

mOPV1

Monovalent type 1 oral poliovirus vaccine (mOPV1) containing at least106 TCID50 of Sabin- strain poliovirus type 1.

DRUG

bOPV 1,3

The bivalent vaccine containing at least 106 CCID50 of Sabin poliovirus type 1 and 105•8 CCID50 of Sabin poliovirus type 3.

Trial Locations (2)

74800

Aga Khan University, Karachi

Unknown

Aga Khan University, Karachi

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Aga Khan University

OTHER

NCT01586572 - Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3 | Biotech Hunter | Biotech Hunter